Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Epidemiology of hyperuricemia and gout Luk AJ; Simkin PAAm J Manag Care 2005[Nov]; 11 (15 Suppl): S435-42; quiz S465-8Gout is an increasingly common medical problem. The traditional risk factors of male sex and high red meat or alcohol consumption have been joined by a wave of newer risk factors, such as increased longevity, the metabolic syndrome (hypertension, diabetes, dyslipidemia, truncal obesity, increased cardiovascular disease risk), use of diuretics, low-dose aspirin, or cyclosporine, and end-stage renal disease. Atypical presentations of gout in the elderly can mimic osteoarthritis and rheumatoid arthritis. There is a resurgence of interest in hyperuricemia as an independent and potentially modifiable cardiovascular risk factor. The pharmacologic management of gout in general practice suffers from a number of quality-control issues. This article reviews these and other new epidemiologic data on this ancient disease.|Adult[MESH]|Age Distribution[MESH]|Aged[MESH]|Aged, 80 and over[MESH]|Cardiovascular Diseases/epidemiology[MESH]|Comorbidity[MESH]|Feeding Behavior[MESH]|Female[MESH]|Global Health[MESH]|Gout Suppressants/therapeutic use[MESH]|Gout/*epidemiology/therapy[MESH]|Humans[MESH]|Hyperuricemia/*epidemiology/therapy[MESH]|Incidence[MESH]|Male[MESH]|Metabolic Syndrome/epidemiology[MESH]|Middle Aged[MESH]|Prevalence[MESH]|Risk Factors[MESH]|Sex Distribution[MESH] |
